$37.060
-0.267 (-0.72%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
GRDN Prediction & Forecast by Similar Chart Analysis
Alphio's GRDN stock price prediction model matches the current Guardian Pharmacy Services Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $37.16 (+0.28%). The 1-week path is $36.96 (-0.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Guardian Pharmacy Services Inc Stock?
Guardian Pharmacy Services Inc is currently trading at $37.06, which is below the analyst price targets ranging from $47 to $49. However, the stock has a low RSI of 30.231, indicating it may be oversold, and a forward P/E of 29.0698 suggests it is relatively expensive compared to its earnings potential. The recent leadership changes and mixed revenue forecasts pose risks, particularly as the stock has seen a 6.25% decline over the last 20 days. Given these factors, it may be prudent to hold rather than buy at this time.
GRDN stock price ended at $37.06 on Friday, after losing -0.72%
Guardian Pharmacy Services Inc (GRDN) last closed at $37.06, losing -0.72%. These facts feed the 1-day and 1-week GRDN price prediction above.
Forecast Drivers
Guardian Pharmacy Services Inc (GRDN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches GRDN, ranked by similarity.
Seasonality analysis for GRDN
Historically the probability of a positive August return for GRDN is 97.56%. April offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.